Seguici su acebook facebook Cerca nel sito:

Le ricerche di Gerona 2005

(09-01-09) Osteoporosis Drugs May Suppress Bones' Ability to Heal



by David Gutierrez,
staff writer

The long-term use of osteoporosis drugs known as bisphosphonates can actually weaken bones by impairing their ability to heal, leading to fractures, according to a study conducted by researchers from New
York-Presbyterian Hospital/Weill Cornell Medical Center.

Researchers reviewed the files of all 70 people who had been admitted to the hospital's Level 1 trauma center between 2002 and 2007 for fractures of the thigh bone (femur).
Fifty-nine of the patients were women, and 25 were taking the bisphosphonate drug Fosamax, known generically as bisphosphonate alendronate.

Of the 20 people who had suffered a stress fracture due to very little or even no trauma, 19 were taking Fosamax. The other individual had cancer.

The researchers also found that Fosamax patients with this type of fracture had been taking the drug longer by an average of 6.9 years, compared with an average of 2.5 years in those with other kinds of fractures. The correlation between Fosamax and stress fractures was found to be independent of age, race, weight or osteoporosis
history.

"While bisphosphonates like Fosamax have been proven to successfully
treat osteoporosis and other metabolic bone disease, we believe long-term use of these drugs may suppress the ability of bones to heal in some patients," said researcher Dean G. Lorich. "As a consequence, patients with routine stress fractures are unable to properly heal, and minor damage can worsen until a serious fracture occurs."

Bisphosphonates interfere with the activity of osteoclasts, which break down bones in order to transfer calcium into the blood.

"While more research is necessary to confirm our results, physicians
prescribing bisphosphonates for longer durations should monitor patients for indications of bone regeneration," researcher Joseph M. Lane said.

While the correlation with fractures has so far only emerged in Fosamax, researchers noted that other bisphosphonate drugs are less widely prescribed and have not been on the market as long, so the effects may not have had time to show up.


Sources for this story include: www.upi.com.
NaturalNews

News

  • (30-08-2018) The electronics in fluorescent bulbs and light emitting diodes (LED), rather than ultraviolet radiation, cause increased malignant melanoma incidence in indoor office workers and tanning bed users

    Leggi tutto

  • (30-08-2018) Mitocondri e peso forma

    Leggi tutto

  • (29-08-2018) Stroke now impacting younger patients as a result of the obesity epidemic; 4 in 10 are now aged 40-69

    Leggi tutto

  • (29-08-2018) Perdere peso non vuol dire perdere osso!

    Leggi tutto

  • (29-08-2018) Brain cholesterol: long secret life behind a barrier.

    Leggi tutto

  • (29-08-2018) Stile di vita sano? Si può, basta usare la fantasia

    Leggi tutto

  • (22-08-2018) Top 10 medical treatments that can make you SICKER than before you took them

    Leggi tutto

  • (22-08-2018) Meno ansia - C’è una associazione tra dieta e disturbi mentali?

    Leggi tutto

  • (22-08-2018) Dietary curcumin supplementation attenuates inflammation, hepatic injury and oxidative damage in a rat model of intra-uterine growth retardation.

    Leggi tutto

  • (22-08-2018) Dopo la gravidanza - Una dieta a basso indice glicemico se serve perdere peso

    Leggi tutto

  • (21-08-2018) Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.

    Leggi tutto

  • (21-08-2018) Anche i neo-papà soffrono della depressione post partum

    Leggi tutto


In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.

Informazioni utili